GGrantIndex
Sort

172,184 grants matching inflammation

Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma

$1,494,947
Joel Barry Baseman · University Of Texas Hlth Science Center · U19 · FY2009 · AI

Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases

$1,494,684
Chi-Chao Chan · National Eye Institute · ZIA · FY2011 · EY

Longitudinal Evaluation of Ovarian Aging and Cardiovascular Risk

$1,494,636
Marcelle Ivonne Cedars · University Of California, San Francisco · R01 · FY2018 · AG

Pre- and Postnatal Exposure Periods for Child Health: Common Risks and Shared Mechanisms

$1,494,602
Thomas G O'Connor · University Of Rochester · UG3 · FY2016 · OD

Role of the Arterial Wall in Atherosclerosis

$1,494,418
Boston University Medical Campus · P01 · FY2004 · HL

Effects of Inhaled Florida Red Tide Brevetoxins

$1,494,310
Daniel G Baden · University Of North Carolina Wilmington · P01 · FY2010 · ES

Pharmacogenomics of Anti-platelet Agents for CVD Prevention

$1,494,237
Alan R. Shuldiner · University Of Maryland Baltimore · U01 · FY2009 · GM

Improving awareness of women with hypertension: ROAR (Rural, Obese, At Risk)

$1,493,938
Jennifer C Sullivan · Augusta University · U54 · FY2025 · HL

Preclinical assessment of a novel compound for treating radiation-induced oral mucositis

$1,493,635
Colton Joseph Lloyd · Sinopia Biosciences, Inc. · R44 · FY2024 · DE

Identification of human genes of iron homeostasis

$1,493,550
Caroline Philpott · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK

Interleukin 4

$1,493,478
William Paul · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Chemical Coding Of Neurotransmission

$1,493,463
Lee E. Eiden · National Institute Of Mental Health · ZIA · FY2010 · MH

Aging Well with HIV through Alcohol Research and Risk Reduction and Education (AWAR3E) Center

$1,493,442
Amy Caroline Justice · Yale University · P60 · FY2025 · AA

Role of inflammation, innate resistance, and immunity in carcinogenesis.

$1,493,249
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Multi-method investigation and characterization of the ocular microbiome

$1,493,152
Cintia Sade De Paiva · Baylor College Of Medicine · U24 · FY2025 · EY

UAB-MISS WIHS Cohort

$1,493,020
Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2014 · AI

HIV Disease Outcomes in Drug Users in Clinical Practice

$1,492,893
Richard Douglas Moore · Johns Hopkins University · U01 · FY2016 · DA

Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection

$1,492,743
Aileen Chang · George Washington University · U01 · FY2023 · AR

Center on Intersystem Regulation by Drugs of Abuse

$1,492,617
Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2021 · DA

Center on Intersystem Regulation by Drugs of Abuse

$1,492,617
Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2024 · DA

Center on Intersystem Regulation by Drugs of Abuse

$1,492,617
Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2023 · DA

Center on Intersystem Regulation by Drugs of Abuse

$1,492,617
Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2022 · DA

Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias

$1,492,444
Anumantha Gounder Kanthasamy · University Of Georgia · U01 · FY2024 · AG

Emory Specialized Center of Research Excellence (SCORE) on Sex Differences

$1,492,185
Ighovwerha Ofotokun · Emory University · U54 · FY2021 · AG

Etiology and outcome of MIS-C

$1,491,907
Betty Diamond · Feinstein Institute For Medical Research · U19 · FY2020 · AI